中文

Credit & Capital

How do you account for a SAFE Agreement on a Cap Table
Credit & Capital

How do you account for a SAFE Agreement on a Cap Table

A company raised $525,000 through a SAFE agreement, but due to the uncertainty of future share conversion amounts, the finance team temporarily recorded the funds as an investment item. Based on its existing cap table, this article analyzes how the SAFE is presented in the table and points out potential information distortion and subsequent adjustment needs that may arise from this treatment.

Stock Split - Issuer Side
Credit & Capital

Stock Split - Issuer Side

This article raises questions about whether issuers can adopt non-integer ratios (such as a 1-for-3 split) in stock splits, and analyzes the resulting fractional shares and accounting treatment issues, aiming to clarify relevant regulatory restrictions and practical feasibility.

Difference between Regulatory Reporting & External Reporting.
Credit & Capital

Difference between Regulatory Reporting & External Reporting.

Aimed at job seekers who have received job information for regulatory reporting and external reporting positions, this article clarifies the differences between the two from dimensions such as definition, purpose, audience, and compliance requirements, and analyzes their potential advantages in career growth, providing a reference for career planning.

Pricing Asset Backed Hard Money Loans
Credit & Capital

Pricing Asset Backed Hard Money Loans

The investor's small business primarily engages in asset-backed bridge loans (typically with terms of 2 to 24 months) and now plans to secure a credit line backed by existing collateral to expand lending scale. The investor asks what type of lender to approach and acceptable terms, noting that most banks show limited interest in such business.

How do I negotiate a covenant cure clause?
Credit & Capital

How do I negotiate a covenant cure clause?

This article focuses on the borrower's request to introduce a covenant cure clause in bank or other financing agreements, analyzes its core advantages (such as a 10-30 day cure period), and shares practitioners' practical negotiation experiences and recommendations.

Line of Credit Pricing
Credit & Capital

Line of Credit Pricing

The enterprise plans to renew its bank credit line, with existing pricing at L+115. The company has excellent credit and uses the facility solely for seasonal working capital needs. This article outlines its pricing questions and invites industry feedback and independent data references.

Debt and Equity
Credit & Capital

Debt and Equity

This article analyzes whether a family business with no debt, ample cash, and low dividends should proactively introduce debt, and outlines other potential advantages beyond the tax shield, such as optimization of capital costs, strengthened financial discipline, and signaling effects.

Debt Matching
Credit & Capital

Debt Matching

Financial theory typically recommends matching long-term assets with long-term debt and short-term assets with short-term debt. However, young or financially constrained enterprises may need to borrow long-term to purchase inventory. Based on the premise of strong market demand and sellable inventory, this article analyzes the feasibility of long-term borrowing and repayment strategies after sufficient cash flow becomes available.

Business Payment terms
Credit & Capital

Business Payment terms

A company has cooperated with a supplier for over 30 years, with original payment terms of a 2% discount and net 20 days. Now the supplier has unilaterally changed the payment period to net 30 days without negotiation. This article analyzes its legality and provides recommendations from the perspectives of contract and commercial practice.